ARYD ARYA Sciences Acquisition Corp IV
- 11.415
- 0.0000.00%
ARYA Sciences Acquisition Corp IV News
ARYA Sciences Acquisition Corp IV | 10-Q/A: Quarterly report (Amendment)
ARYA Sciences Acquisition Corp IV | 10-Q: Quarterly report
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to
Express News | ARYA Sciences Acquisition Corp IV - Adagio Letter Approving Increase in Number of Study Sites, Subjects in Study for Vclas Cryoablation System
Express News | ARYA Sciences Acquisition Corp IV - on April 26, Adagio Received a Letter From U.S. FDA
Adagio Medical to Go Public in $113M Deal With SPAC ARYA Sciences
Arya, Adagio Medical: Combined Company to Receive $42M From Equity, Convertible Note Investors at Closing >ARYD
Arya, Adagio Medical: Combined Company to Receive $42M From Equity, Convertible Note Investors at Closing >ARYD
Adagio Medical to List on Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV >ARYD
Adagio Medical to List on Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV >ARYD
Arya Sciences Acquisition to Redeem Shares
By Sabela Ojea Arya Sciences Acquisition said Monday it is redeeming shares, as it won't consummate a business combination with a third party within the required timeline. The special purpose acquis
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Trading Down 0.2%
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating)'s share price dropped 0.2% during mid-day trading on Thursday . The stock traded as low as $10.32 and last traded at $10.33. Approximately
ARYA Sciences Acquisition IV Corp Announced It Would Restate The Financial Statements Included In The Quarterly Report In The Annual Report On Form 10-K For The Year Ended December 31, 2022
https://www.sec.gov/ix?doc=/Archives/edgar/data/1838821/000114036123016524/brhc10050928_8k.htm
Toronto Dominion Bank Makes New $289,000 Investment in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
Toronto Dominion Bank purchased a new position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) in the third quarter, HoldingsChannel reports. The institutional investor purchased 29,
Woodline Partners LP Raises Stake in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
Woodline Partners LP increased its stake in shares of ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) by 51.0% during the second quarter, according to its most recent filing with the SE
Aerie Pharmaceuticals (NASDAQ:AERI) Vs. ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Head to Head Survey
Aerie Pharmaceuticals (NASDAQ:AERI – Get Rating) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) are both small-cap medical companies, but which is the better investment? We will com
Aerie Pharmaceuticals (NASDAQ:AERI) & ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Critical Comparison
Aerie Pharmaceuticals (NASDAQ:AERI – Get Rating) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) are both small-cap medical companies, but which is the better investment? We will con
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Shares Up 0.1%
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating)'s share price shot up 0.1% during trading on Monday . The company traded as high as $9.93 and last traded at $9.93. 102 shares changed han
Sculptor Capital LP Has $6.55 Million Stock Position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
Sculptor Capital LP lifted its stake in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) by 4.1% in the first quarter, according to its most recent filing with the Securities & Excha
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Trading Up 0.1%
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating)'s share price was up 0.1% on Monday . The stock traded as high as $9.92 and last traded at $9.92. Approximately 2,412 shares changed hands
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and Iovance Biotherapeutics (NASDAQ:IOVA) Head to Head Analysis
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) and Iovance Biotherapeutics (NASDAQ:IOVA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will
Bank of Nova Scotia Takes $1.48 Million Position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)
Bank of Nova Scotia acquired a new stake in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Rating) in the first quarter, according to the company in its most recent 13F filing with the SEC. Th
Analysis
Price Target
No Data
